Reshape Lifesciences Inc's Customers Performance

Name: Reshape Lifesciences Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

RSLS

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


RSLS's Source of Revenues		During the corresponding time, Reshape Lifesciences Inc saw a revenue deteriorated by -97.16 % year on year, While revenue at the Reshape Lifesciences Inc's corporate clients • List of RSLS Customers

for the same period Reshape Lifesciences Inc revnue deteriorated by -97.16 % year on year,

• List of RSLS Customers

Reshape Lifesciences Inc's Business Units


Rest of World		25 %	of total Revenue

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Reshape Lifesciences Inc's Comment on Sales, Marketing and Customers

The text addresses regulatory requirements and processes involved in drug development and approval by the FDA and other regulatory authorities. It does not specify any customers or market segments served.

News about Reshape Lifesciences Inc Contracts

Collaborating for a Cure ReShape Lifesciences and USC’s CARSS Innovate Next-Gen Diabetes Treatment,

Unveiling the Future of Diabetes Management: ReShape Lifesciences and USC s CARSS Invest in Groundbreaking Neuromodulation Technology In an exciting development for the diabetes treatment landscape, ReShape Lifesciences, a pioneer in weight-loss solutions, has announced a strategic collaboration with the University of Southern California s Center for Autonomic Nerve Recording and Stimulation Systems (CARSS). This promising partnership has secured a supplementary grant of approximately $241,000 from the National Institutes of Health (NIH) to advance the development of next-generation electrodes, crucial for ReShape s innovative Diabetes Bloc-Stim Neuromodulation Technology. At the intersection of cutting-edge...

Reshape Lifesciences Inc’s Comment on Sales, Marketing and Customers

RSLS's Stock Performance relative to it's Customers

RSLS's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Reshape Lifesciences Inc	26.23	2.42	-10.74	18
SUBTOTAL	0.00	0.00	0.00	-

Sources: Reshape Lifesciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Reshape Lifesciences Inc’s corporate clients.
For your research, we’ve provided 9 tables on Reshape Lifesciences Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.